Global Androgen Replacement Therapy Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global androgen replacement therapy market over the forecast period. This is due to the increasing number of product launches in the region. For instance, on March 2022, the U.S. Food And Drug Administration (FDA) approved testosterone undecanoate capsules called (Tlando), an oral testosterone replacement therapy in the U.S. hypogonadism market. The approval was given to Antares Pharma, a U.S-based specialty pharmaceutical company.
Androgen Replacement Therapy Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients